Sanolla Launches the World’s First Smart AI-powered Stethoscope Offering Full-Spectrum Auscultation

The company opens direct sales of FDA-Certified VoqX, empowering clinicians with AI-powered diagnostics.

HOUSTON, Sept. 25, 2025 /PRNewswire/ — Sanolla, a leader in advanced auscultation and AI-powered diagnostic tools, is advancing clinical practice with the launch of its VoqX smart stethoscope, the first AI-powered device capable of analyzing both heart and lung sounds, now directly available to physicians.

VoqX is the world’s first smart stethoscope capable of full-spectrum auscultation, including low-frequency infrasound, vital diagnostic information that traditional stethoscopes cannot hear. Combined with real-time AI analysis, it transforms how healthcare professionals detect and manage cardiopulmonary conditions.

VoqX offers superb pulmonary auscultation, where even experienced GPs and nurses notice the difference in elderly patients with chronic lung conditions.

“Offering our groundbreaking stethoscope to the mass market marks an important step in making advanced diagnostic technology more accessible to frontline clinicians,” said Dr. Doron Adler, CEO and co-founder of Sanolla. “VoqX represents a leap forward in auscultation, and we’re excited to make it easier than ever to bring this powerful tool into the hands of those who need it most.”

VoqX captures a wider range of clinical sounds by shifting inaudible body signals into the human hearing range using patented audio technology. Clinically validated AI algorithms, trained on tens of thousands of recordings, analyze these sounds in real time, offering immediate insights that support earlier and more accurate diagnosis.

From heart failure and valvular disease to respiratory complications, VoqX helps users detect anomalies that would otherwise go unnoticed. Whether used by physicians, nurses, paramedics, or home care providers, VoqX adds a new layer of intelligence to one of medicine’s oldest tools.

VoqX is as intuitive as a traditional stethoscope, but far more powerful. It features:

  • A built-in display for real-time feedback
  • The ability to record and store clinical sound files
  • Edge-AI supported diagnostic interpretation
  • Compact, durable design suited for hospitals, clinics, and field environments

VoqX is certified by the FDA, compliant with ISO 13485, and protected by international patents.

VoqX is now offered on Sanolla’s official website at a limited-time introductory price of $499, a significant reduction from the standard $750.

About Sanolla

Sanolla develops AI-powered diagnostic tools that empower clinicians to hear more, detect earlier, and diagnose better. With a mission to transform traditional auscultation through advanced technology, Sanolla is shaping the future of frontline care.

For more information, visit: https://sanolla.com/

Contact

Dan Gerstenfeld
Interteam
+972-52-3745989
dan@interteam.co.il

View original content:https://www.prnewswire.com/news-releases/sanolla-launches-the-worlds-first-smart-ai-powered-stethoscope-offering-full-spectrum-auscultation-302567028.html

SOURCE Sanolla

Staff

Recent Posts

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…

6 hours ago

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

8 hours ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

8 hours ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

11 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

14 hours ago